Cargando…

Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia

BACKGROUND: The detection of hepatitis B virus surface antigen (HBsAg) in serum remains the mainstay in diagnosing and screening of hepatitis B virus (HBV) in most developing countries. The absence of HBsAg in the blood may not indicate the absence of circulating HBV and might be infectious. Thus, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Beykaso, Gizachew, Mulu, Andargachew, Giday, Mirutse, Berhe, Nega, Selamu, Markos, Hailu, Dawit, Teklehaymanot, Tilahun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886027/
https://www.ncbi.nlm.nih.gov/pubmed/35241914
http://dx.doi.org/10.2147/IDR.S344668
_version_ 1784660560159178752
author Beykaso, Gizachew
Mulu, Andargachew
Giday, Mirutse
Berhe, Nega
Selamu, Markos
Hailu, Dawit
Teklehaymanot, Tilahun
author_facet Beykaso, Gizachew
Mulu, Andargachew
Giday, Mirutse
Berhe, Nega
Selamu, Markos
Hailu, Dawit
Teklehaymanot, Tilahun
author_sort Beykaso, Gizachew
collection PubMed
description BACKGROUND: The detection of hepatitis B virus surface antigen (HBsAg) in serum remains the mainstay in diagnosing and screening of hepatitis B virus (HBV) in most developing countries. The absence of HBsAg in the blood may not indicate the absence of circulating HBV and might be infectious. Thus, this study aimed to estimate the burden and its cryptic transmission risks of occult hepatitis B infection (OBI) among HBsAg negative healthy individuals in Southern Ethiopia. METHODS: A community-based cross-sectional study was conducted from September 2020 to January 2021. Serum samples were collected and assayed for HBsAg and HBV core antibody (anti-HBc) seromarkers using enzyme-linked immunosorbent assay (ELISA). In anti-HBc positive samples, HBV DNA was detected using real-time polymerase chain reaction (RT-PCR). Data were entered into Epi-Data version 3.1, cleaned, and analyzed using SPSS version 21.0. Descriptive and logistic regression analyses were employed. Statistical significance was decided at p < 0.05. RESULTS: A total of 346 were individuals included in this study; 34 (9.8%) were tested positive for HBsAg. The rest 312 (90.2%) negatively tested were further assayed for anti-HBc, and 115 (36.7%) were found positive implying previous exposure to HBV, and 21 (18.3%) out of 115 anti-HBc positives had HBV DNA signifying OBI. The HBV DNA concentration below 200 IU/mL was 85.7%. A high rate of OBI was observed among individuals who had multiple sexual contacts, a family history of hepatitis, and tattooing. CONCLUSION: In this study, the prevalence of OBI is high. This indicates the burden of HBV is considerable since screening is exclusively dependent on HBsAg which will not eliminate the possibility of residual cryptic transmission through blood donation, organ transplantation, perinatal transmission, and other contacts. Our results demonstrate that nucleic acid-based testing (NAT) should be an essential part of screening to prevent missing OBI.
format Online
Article
Text
id pubmed-8886027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-88860272022-03-02 Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia Beykaso, Gizachew Mulu, Andargachew Giday, Mirutse Berhe, Nega Selamu, Markos Hailu, Dawit Teklehaymanot, Tilahun Infect Drug Resist Original Research BACKGROUND: The detection of hepatitis B virus surface antigen (HBsAg) in serum remains the mainstay in diagnosing and screening of hepatitis B virus (HBV) in most developing countries. The absence of HBsAg in the blood may not indicate the absence of circulating HBV and might be infectious. Thus, this study aimed to estimate the burden and its cryptic transmission risks of occult hepatitis B infection (OBI) among HBsAg negative healthy individuals in Southern Ethiopia. METHODS: A community-based cross-sectional study was conducted from September 2020 to January 2021. Serum samples were collected and assayed for HBsAg and HBV core antibody (anti-HBc) seromarkers using enzyme-linked immunosorbent assay (ELISA). In anti-HBc positive samples, HBV DNA was detected using real-time polymerase chain reaction (RT-PCR). Data were entered into Epi-Data version 3.1, cleaned, and analyzed using SPSS version 21.0. Descriptive and logistic regression analyses were employed. Statistical significance was decided at p < 0.05. RESULTS: A total of 346 were individuals included in this study; 34 (9.8%) were tested positive for HBsAg. The rest 312 (90.2%) negatively tested were further assayed for anti-HBc, and 115 (36.7%) were found positive implying previous exposure to HBV, and 21 (18.3%) out of 115 anti-HBc positives had HBV DNA signifying OBI. The HBV DNA concentration below 200 IU/mL was 85.7%. A high rate of OBI was observed among individuals who had multiple sexual contacts, a family history of hepatitis, and tattooing. CONCLUSION: In this study, the prevalence of OBI is high. This indicates the burden of HBV is considerable since screening is exclusively dependent on HBsAg which will not eliminate the possibility of residual cryptic transmission through blood donation, organ transplantation, perinatal transmission, and other contacts. Our results demonstrate that nucleic acid-based testing (NAT) should be an essential part of screening to prevent missing OBI. Dove 2022-02-24 /pmc/articles/PMC8886027/ /pubmed/35241914 http://dx.doi.org/10.2147/IDR.S344668 Text en © 2022 Beykaso et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Beykaso, Gizachew
Mulu, Andargachew
Giday, Mirutse
Berhe, Nega
Selamu, Markos
Hailu, Dawit
Teklehaymanot, Tilahun
Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia
title Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia
title_full Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia
title_fullStr Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia
title_full_unstemmed Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia
title_short Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia
title_sort occult hepatitis b virus infection and its risks of cryptic transmission in southern ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886027/
https://www.ncbi.nlm.nih.gov/pubmed/35241914
http://dx.doi.org/10.2147/IDR.S344668
work_keys_str_mv AT beykasogizachew occulthepatitisbvirusinfectionanditsrisksofcryptictransmissioninsouthernethiopia
AT muluandargachew occulthepatitisbvirusinfectionanditsrisksofcryptictransmissioninsouthernethiopia
AT gidaymirutse occulthepatitisbvirusinfectionanditsrisksofcryptictransmissioninsouthernethiopia
AT berhenega occulthepatitisbvirusinfectionanditsrisksofcryptictransmissioninsouthernethiopia
AT selamumarkos occulthepatitisbvirusinfectionanditsrisksofcryptictransmissioninsouthernethiopia
AT hailudawit occulthepatitisbvirusinfectionanditsrisksofcryptictransmissioninsouthernethiopia
AT teklehaymanottilahun occulthepatitisbvirusinfectionanditsrisksofcryptictransmissioninsouthernethiopia